3,738 followers
RT @FrontEndocrinol: New Research: Weight and Glycemic Control Outcomes of Bariatric Surgery and Pharmacotherapy in Patients With Melanocor…
RT @FrontEndocrinol: New Research: Weight and Glycemic Control Outcomes of Bariatric Surgery and Pharmacotherapy in Patients With Melanocor…
New Research: Weight and Glycemic Control Outcomes of Bariatric Surgery and Pharmacotherapy in Patients With Melanocortin-4 Receptor Deficiency: Background Melanocortin-4 receptor (MC4R) mutations are the most common of the rare… https://t.co/w7cup1ZBqz #